Search Results - "Gali, Radhika"

Late-Onset Cytokine Release Syndrome (CRS) in HIV Patient with Relapsed Classical Hodgkin Lymphoma on Nivolumab and Non-Compliance with Anti-Retroviral Therapy by Gali, Radhika, Alejos, David, Mantzaris, Ioannis

“…PD-1 inhibitors have emerged as an important class of immunotherapy drugs and several agents, such as nivolumab, are now FDA approved for the treatment of…”
Get full text

Seroconversion rates following COVID-19 vaccination among patients with cancer by Thakkar, Astha, Gonzalez-Lugo, Jesus D., Goradia, Niyati, Gali, Radhika, Shapiro, Lauren C., Pradhan, Kith, Rahman, Shafia, Kim, So Yeon, Ko, Brian, Sica, R. Alejandro, Kornblum, Noah, Bachier-Rodriguez, Lizamarie, McCort, Margaret, Goel, Sanjay, Perez-Soler, Roman, Packer, Stuart, Sparano, Joseph, Gartrell, Benjamin, Makower, Della, Goldstein, Yitz D., Wolgast, Lucia, Verma, Amit, Halmos, Balazs

“…As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically needed. Using a validated antibody assay against SARS-CoV-2 spike…”
Get full text

COVID-19 infections among minority patients with gastrointestinal malignancies in urban safety net academic medical centers by Gali, Radhika, Viteri Malone, Mariuxi Alexandra, Goel, Sanjay

“…e15610 Background: COVID 19 infection has worse outcomes and is more severe among frail patients and with co-morbidities. Additionally, it was suggested by…”
Get full text

Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric Surgery by Kushnir, Margarita, Gali, Radhika, Alexander, Mariam, Billett, Henny Heisler H.

“…Background: Over 200,000 people underwent weight loss surgery in the United States in 2017. The absorption of numerous drugs has been shown to be altered in…”
Get full text

Assessing Clinical Outcomes in Patients Undergoing Splenectomy for Immune Thrombocytopenia: A Real World Perspective by Rabinovich, Emma, Pradhan, Kith, Davido, Helen Tracy, Gali, Radhika, Islam, Iffath, Muscarella, Peter, Billett, Henny H.

“…Background: Immune thrombocytopenia (ITP) is an acquired immune-mediated disorder characterized by frequent relapses. Splenectomy was considered an integral…”
Get full text

Paradoxical association of B7H3 with clinical outcomes in patients with colorectal cancer by Huang, Yan, Qi, Xiaohua, Acuna-villaorduna, Ana, Gali, Radhika, Maitra, Radhashree, Lin, Juan, Maia, Catarina, Zhang, Wei, Zhang, Chenxin, Zang, Xingxing, Liu, Qiang, Goel, Sanjay

“…e15508 Background: Immune related biomarkers (IRB) are important predictors of outcome to immune checkpoint inhibitor (ICI) therapy; however, their role is…”
Get full text

Survival analysis of patients with early and standard onset colorectal cancer: A single center study by Patel, Dhruv, Martins Maia, Catarina, Lyudmer, Michael, Tolu, Seda, Chergui, Adel, Patel, Riya Jayesh, Kim, So Yeon, Gali, Radhika, Acuna Villaorduna, Ana, Goel, Sanjay

“…e15512 Background: While more aggressive clinical/pathological features have been consistently described in between patients with early-onset (EO) and…”
Get full text

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery by Kushnir, Margarita, Gali, Radhika, Alexander, Mariam, Billett, Henny H.

Get full text

Expanding the Role of Checkpoint Inhibitors in Immune Cold Tumors by Acuna-Villaorduna, Ana, Gali, Radhika, Chergui, Adel, Goel, Sanjay

Get full text

Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study by Baumann Kreuziger, Lisa, Gaddh, Manila, Onadeko, Oluwatomiloba, George, Gemlyn, Wang, Tzu-Fei, Oo, Thein H., Jaglal, Michael, Houghton, Damon E., Streiff, Michael B., Gali, Radhika, Feng, Mingen, Simpson, Pippa, Billett, Henny H.

“…Optimal treatment of catheter-related thrombosis (CRT) is uncertain in patients with hematologic malignancy. We aimed to evaluate the treatment strategies,…”
Get full text

Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort by Shapiro, Lauren C, Gali, Radhika, Thakkar, Astha, Gonzalez-Lugo, Jesus D, Bazarbachi, Abdul Hamid, Rahman, Shafia, Pradhan, Kith, Fehn, Karen, Abreu, Michelly, Kornblum, Noah, Gritsman, Kira, Goldfinger, Mendel, Shastri, Aditi, Mantzaris, Ioannis, Braunschweig, Ira, Halmos, Balazs, Verma, Amit, McCort, Margaret, Bachier-Rodriguez, Lizamarie, Sica, R. Alejandro

“…It is well established that COVID-19 carries a higher risk of morbidity and mortality in patients (pts) with hematologic malignancies. Emerging data suggests…”
Get full text

Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study by Baumann Kreuziger, Lisa, Gaddh, Manila, Onadeko, Oluwatomiloba, George, Gemlyn, Wang, Tzu-Fei, Oo, Thein H., Feng, Ming, Simpson, Pippa, Gali, Radhika, Billett, Henny Heisler

“…Background: Consensus guidelines recommend anticoagulation for 3 months in patients with upper extremity catheter-related thrombosis (CRT); however,…”
Get full text

Splenomegaly and Response to Splenectomy in Immune Thrombocytopenia by Rabinovich, Emma, Pradhan, Kith, Islam, Iffath, Davido, Helen Tracy, Gali, Radhika, Muscarella, Peter, Billett, Henny H

“…: Immune thrombocytopenia (ITP) is an acquired autoimmune disorder affecting patients of all ages and backgrounds. While current standards favor medical…”
Get full text

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination by Shapiro, Lauren C., Thakkar, Astha, Gali, Radhika, Gonzalez-Lugo, Jesus D., Bazarbachi, Abdul-Hamid, Rahman, Shafia, Pradhan, Kith, Fehn, Karen, Abreu, Michelly, Kornblum, Noah, Gritsman, Kira, Goldfinger, Mendel, Shastri, Aditi, Mantzaris, Ioannis, Braunschweig, Ira, Halmos, Balazs, Verma, Amit, McCort, Margaret, Bachier-Rodriguez, Lizamarie, Sica, R. Alejandro

Get full text

Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study by Houghton, Damon E., Billett, Henny Heisler H., Gaddh, Manila, Onadeko, Oluwatomiloba, George, Gemlyn, Wang, Tzu-Fei, Oo, Thein H., Sun, Yuanyue, Feng, Mingen, Jaglal, Michael, Streiff, Michael B., Simpson, Pippa, Gali, Radhika, Baumann Kreuziger, Lisa

“…▪ Background: Standard treatment for catheter-associated upper extremity deep vein thrombosis (UEDVT) is anticoagulation. If catheter removal is otherwise…”
Get full text

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis by Houghton, Damon E., Billett, Henny Heisler, Gaddh, Manila, Onadeko, Oluwatomiloba, George, Gemlyn, Wang, Tzu-Fei, Oo, Thein H., Feng, Mingen, Dasgupta, Mahua, Jaglal, Michael, Streiff, Michael B., Simpson, Pippa, Gali, Radhika, Baumann Kreuziger, Lisa

“…Standard treatment of catheter-associated upper extremity deep vein thrombosis (UE-DVT) is anticoagulation, although catheters are often removed for this…”
Get full text